China Cell Therapy Party On: $500m+ Raised In JW IPO, Other Rounds

CAR-T Developer Plans US, Europe Expansion

 
• By Brian Yang

It's been a big week for cell therapy developers in China with well over $500m raised through an IPO and large new funding rounds for several other ventures.

DIA panel on CAR-T in China, held in Suzhou Oct. 26, 2018
WUXI APPTEC COO STEVE YANG (FAR RIGHT) AND FOSUN-KITE CEO RICHARD WANG (FIRST LEFT) AT THE DIA CHINA MEETING IN 2018 • Source: Courtesy of DIA

More from Gene Therapies

More from Advanced Therapies